Table of Contents

Part 1. Epidemiology.
Epidemiology of Basal Cell and Squamous Cell Carcinoma of the Skin.
Epidemiology of Malignant Melanoma.
Epidemiology of Cutaneous Lymphomas.
Epidemiology of Histocytoses.
Epidemiology of Kaposi Sarcoma.
Epidemiology of Dermatofibrosarcoma Protuberans.
Epidemiology of Merkel Cell Carcinoma.
Part 2. Pathogenesis.
Pathogenesis of Nonmelanoma Skin Cancer.
Pathogenesis of Malignant Melanoma.
Pathogenesis of Primary Cutaneous Lymphomas.
Pathogenesis of Histiocytoses.
Pathogenesis of Kaposi Sarcoma.
Pathogenesis of Dermatofibrosarcoma Protuberans.
Pathogenesis of Merkel Cell Carcinoma.
Part 3. Disease entities.
Nonmelanoma Skin Cancer: Keratinocytic Tumors.
Non-Melanoma Skin Cancer: Appendageal Tumours.
Melanocytic Tumors.
Cutaneous Lymphoma, Leukemia and Related Disorders.
Histiocytoses.
Mastocytosis, Vascular, Muscular and Fibrohistiocytic Tumors.
Neural Tumors.
Part 4. Therapy.
Non-Melanoma Skin Cancer.
Melanoma.
Cutaneous Lymphoma.
Other Therapies.
Part 5. Diagnostics.
Dermoscopy.
PET and PET/CT of Malignant Melanoma. The dramatic increase in the incidence of skin cancers is a major concern worldwide and relates not only to melanoma but also to other cancers, including Merkel cell and basal cell carcinomas. Recently, the WHO has summarized the genetic and pathologic features of skin cancers in its book series. However, the WHO's proposed classification of certain disease entities, such as basal cell carcinomas, is still novel for many dermatologists. This book covers the entire spectrum of cutaneous malignancies in accordance with the new WHO classification. Epidemiology, pathogenesis, diagnosis, and therapy are all reviewed in detail, and care is taken to link the diagnostic and genetic features to optimized therapeutic strategies.--